The success of the mRNA vaccines for COVID-19 led to explosive growth in lipid nanoparticle (LNP)-mediated drug delivery for RNA vaccines and therapeutics. As these projects scale into clinical trials ...

The track by which API manufacturing processes are prepared for commercial use is comparable to overlapping integrative process evaluations at commercial scale. This ensures the process is ...

FREMONT, Calif.--(BUSINESS WIRE)--Tivic Health® Systems, Inc. (Nasdaq: TIVC), a diversified therapeutics company, announced today it has entered a definitive agreement with Scorpius BioManufacturing ...

The biopharmaceutical industry is expanding rapidly, driven by an increasing demand for complex biomedicines. Today, manufacturing biomolecules presents unique challenges, like cost pressure and ...

Highly potent active pharmaceutical ingredients (HPAPIs) are at the forefront of pharmaceutical manufacturing. They are particularly common in targeted therapies and personalized medicines. This is ...

As demand for precision medicine accelerates, CAR T and CAR Treg cell therapies are emerging as crucial tools in the fight against cancer and autoimmune diseases. For Thomas Fellner, PhD, head of ...

Lifecore Biomedical, Inc. announced a new 10-year commercial manufacturing and supply agreement with one of its existing customers to support the development of a novel ophthalmic therapeutic. This ...

The two companies have announced an agreement to collaboratively explore technical and process opportunities to optimise commercial production of TRISO nuclear fuel to supply Kairos Power's advanced ...

SOMERVILLE, Mass.--(BUSINESS WIRE)--Sublime Systems, developers of a fossil-fuel-free, scalable, drop-in replacement for traditional cement in concrete, announced it has secured the site for its first ...

USA Rare Earth, Inc. (Nasdaq: USAR) (USAR or the Company) today announced a significant acceleration of the commercialization timeline for its Round Top heavy rare earth deposit in Texas. The Company ...